OK Biotech Co., Ltd.

NT$17.90As of Sun 8 Nov 2026, 12:00 UTC
TWSE:4155Healthcare
Country Taiwan
PE (Fwd) •••
TSR 10Y CAGR (0.32%)
Div yield 1.87%
ROE 10.29%
Medical Devices
Beta (5Y) 0.24
PE TTM 9.594
TSR TTM 25.08%
Mkt cap NT$2.201B
ROIC 5.96%
SE Grade™
Value
Quality
Moat
Consensus
Reference
NT$18
2.68%
(7.76%)
Hold 9|12|2|1|10
4Q25
1Q26
2Q26
3Q26
Earnings per shareNT$
0.19
0.19
0.21
0.20
0.28%
0.87%
14.72%
13.89%
RevenueNT$M
173.7
172.8
171.8
180.8
1.26%
0.65%
(0.90%)
4.06%
Peers (US$66.47M)
Cap (US$)
PE
71.32M
12.80x
63.92M
14.56x
66.96M
10.27x
Capital
TTM
5Y
10Y
Leveragex
0.411
5.886
4.465
EBIT/Intx
0.912
0.623
0.587
Own earn%
(318.77)
201.81
181.94
Sh yield%
33.90
19.19
19.22
Owners
Insiders/Inst%
8.73
72.49
Short interest%
4.16
SBC / revenue%
3.93
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
14
Op margin range%
21–32
$1 testx
—
Incr. ROIC%
4